Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company’s privacy policies.
Regeneron, a biotech company, will acquire 23andMe for $256 million and vowed to comply with the genetic testing company’s privacy policies.